暂停向中国市场供应HPV疫苗 默沙东回应每经:系与智飞生物沟通后决定

每日经济新闻
05 Feb

2月4日,默沙东宣布将暂停向中国市场供应佳达修HPV宫颈癌疫苗,此次供应暂停将至少持续至2025年年中。默沙东的HPV疫苗包括四价HPV疫苗(GARDASIL)和九价HPV疫苗(GARDASIL 9),是该公司除K药之外的主要增长动力之一。2024年开始,该疫苗销售放缓。  今日(2月5日),默沙东方面向《每日经济新闻》回应:“受整体市场环境、消费者需求疲软及渠道库存高等因素影响,默沙东与本土...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10